Long-Term Cardiovascular Risks of Psychostimulant Drugs for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

By sjmartinez • May 9, 2024

Alexander GC, Moore TJ, Brass EP. Long-Term Cardiovascular Risks of Psychostimulant Drugs for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). J Am Coll Cardiol. 2024 May 14;83(19):1883-1885. doi: 10.1016/j.jacc.2024.03.409. PMID: 38719368.

Tags: attention deficit disorder with hyperactivity, central nervous system stimulants, Endocrinology, Harbor UCLA, prescribing indicators, prescribing quality, Publications, quality of care

Active Surveillance and Conversion Surgery for Low-Risk Thyroid Cancer-The Disconnect Between Literature and Practice

Ho AS, Davies L, Yeh MW. Active Surveillance and Conversion Surgery for Low-Risk Thyroid Cancer-The Disconnect Between Literature and Practice. JAMA Otolaryngol Head Neck Surg.[...]

LXR signaling pathways link cholesterol metabolism with risk for prediabetes and diabetes

Ding J, Nguyen AT, Lohman K, Hensley MT, Parker D, Hou L, Taylor J, Voora D, Sawyer JK, Boudyguina E, Bancks MP, Bertoni A, Pankow[...]

30 years of (re)productive biology: a symposium honoring professor Martin M. Matzuk, MD, PhD

Kumar TR, Burns KH, Yan W. 30 years of (re)productive biology: a symposium honoring professor Martin M. Matzuk, MD, PhD. Biol Reprod. 2024 May 9;110(5):852-853.[...]